Correction: "Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation" [Molecular and Cellular Biology, 33, 11, (2013) (2163-2177)] Doi: 10.1128/MCB.01019-12;Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation

Molecular and Cellular Biology

Volumn 33, Issue 11, 2013, Pages 2163-2177

  Erker, Yigit ^a   Neyret Kahn, Helene ^b   Seeler, Jacob S ^b   Dejean, Anne ^b   Atfi, Azeddine ^a   Levy, Laurence ^a  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARKADIA PROTEIN; ARSENIC; HETERODIMER; PROMYELOCYTIC LEUKEMIA PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; UBIQUITINATION;

EID: 84878986048     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00193-17     Document Type: Erratum

References (51)

1. Le Scolan E, Zhu Q, Wang L, Bandyopadhyay A, Javelaud D, Mauviel A, Sun L, Luo K. 2008. Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res. 68:3277-3285.
2. Levy L, Howell M, Das D, Harkin S, Episkopou V, Hill CS. 2007. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol. Cell. Biol. 27:6068-6083.
3. Mavrakis KJ, Andrew RL, Lee KL, Petropoulou C, Dixon JE, Navaratnam N, Norris DP, Episkopou V. 2007. Arkadia enhances Nodal/TGFbeta signaling by coupling phospho-Smad2/3 activity and turnover. PLoS Biol. 5:e67. doi:10.1371/journal.pbio.0050067.
4. Koinuma D, Shinozaki M, Komuro A, Goto K, Saitoh M, Hanyu A, Ebina M, Nukiwa T, Miyazawa K, Imamura T, Miyazono K. 2003. Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J. 22:6458-6470.
5. Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, Yuki K, Isogaya K, Saitoh M, Imamura T, Episkopou V, Miyazono K, Miyazawa K. 2007. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling. J. Biol. Chem. 282:20492-20501.
6. Tatham MH, Jaffray E, Vaughan OA, Desterro JM, Botting CH, Naismith JH, Hay RT. 2001. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276:35368-35374.
7. Matic I, van Hagen M, Schimmel J, Macek B, Ogg SC, Tatham MH, Hay RT, Lamond AI, Mann M, Vertegaal AC. 2008. In vitro identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vitro strategy. Mol. Cell. Proteomics 7:132-144.
8. Saitoh H, Hinchey J. 2000. Functional heterogeneity of small ubiquitinrelated protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275: 6252-6258.
9. Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, Palvimo JJ, Hay RT. 2008. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10:538-546.
10. Bruderer R, Tatham MH, Plechanovova A, Matic I, Garg AK, Hay RT. 2011. Purification and identification of endogenous polySUMO conjugates. EMBO Rep. 12:142-148.
11. Golebiowski F, Matic I, Tatham MH, Cole C, Yin Y, Nakamura A, Cox J, Barton GJ, Mann M, Hay RT. 2009. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2:ra24. doi:10.1126 /scisignal.2000282.
12. Martin N, Schwamborn K, Schreiber V, Werner A, Guillier C, Zhang XD, Bischof O, Seeler JS, Dejean A. 2009. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock. EMBO J. 28:3534-3548.
13. Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z. 1996. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/ PML proteins. Blood 88:1052-1061.
14. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, de The H. 2001. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193:1361-1371.
15. Muller S, Miller WH, Jr, Dejean A. 1998. Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the pro- myelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells. Blood 92:4308-4316.
16. Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH, Jr. 1998. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J. Natl. Cancer Inst. 90: 124-133.
17. Zhu J, Koken MH, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z, de The H. 1997. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 94:3978-3983.
18. Wang ZY, Chen Z. 2008. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111:2505-2515.
19. Geoffroy MC, Hay RT. 2009. An additional role for SUMO in ubiquitinmediated proteolysis. Nat. Rev. Mol. Cell Biol. 10:564-568.
20. Heideker J, Perry JJ, Boddy MN. 2009. Genome stability roles of SUMOtargeted ubiquitin ligases. DNA Repair (Amst.) 8:517-524.
21. Nagai S, Davoodi N, Gasser SM. 2011. Nuclear organization in genome stability: SUMO connections. Cell Res. 21:474-485.
22. Perry JJ, Tainer JA, Boddy MN. 2008. A SIM-ultaneous role for SUMO and ubiquitin. Trends Biochem. Sci. 33:201-208.
23. Prudden J, Pebernard S, Raffa G, Slavin DA, Perry JJ, Tainer JA, McGowan CH, Boddy MN. 2007. SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 26:4089-4101.
24. Sun H, Leverson JD, Hunter T. 2007. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 26:4102-4112.
25. Geoffroy MC, Jaffray EG, Walker KJ, Hay RT. 2010. Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies. Mol. Biol. Cell 21:4227-4239.
26. Hakli M, Karvonen U, Janne OA, Palvimo JJ. 2005. SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies. Exp. Cell Res. 304:224-233.
27. Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, Zhou J, Zhu J, Raught B, de The H. 2008. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 10:547-555.
28. Percherancier Y, Germain-Desprez D, Galisson F, Mascle XH, Dianoux L, Estephan P, Chelbi-Alix MK, Aubry M. 2009. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells. J. Biol. Chem. 284:16595-16608.
29. He J, Tegen SB, Krawitz AR, Martin GS, Luo K. 2003. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins. J. Biol. Chem. 278:30540-30547.
30. Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K, Kawabata M. 1999. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with Smads. J. Biol. Chem. 274:35269-35277.
31. Dennler S, Itoh S, Vivien D, Ten Dijke P, Huet S, Gauthier JM. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091-3100.
32. Liu W, Rui H, Wang J, Lin S, He Y, Chen M, Li Q, Ye Z, Zhang S, Chan SC, Chen YG, Han J, Lin SC. 2006. Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia. EMBO J. 25: 1646-1658.
33. Moilanen AM, Poukka H, Karvonen U, Hakli M, Janne OA, Palvimo JJ. 1998. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol. Cell. Biol. 18:5128-5139.
34. Yang SH, Sharrocks AD. 2010. The SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motif. Mol. Cell. Biol. 30:2193-2205.
35. Dellaire G, Ching RW, Dehghani H, Ren Y, Bazett-Jones DP. 2006. The number of PML nuclear bodies increases in early S phase by a fission mechanism. J. Cell Sci. 119:1026 -1033.
36. Kandel ES, Nudler E. 2002. Template switching by RNA polymerase II in vitro. Evidence and implications from a retroviral system. Mol. Cell 10: 1495-1502.
37. Levenson VV, Lausch E, Kirschling DJ, Broude EV, Davidovich IA, Libants S, Fedosova V, Roninson IB. 1999. A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication. Somat. Cell Mol. Genet. 25:9-26.
38. Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y. 2004. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. U. S. A. 101:14373-14378.
39. Episkopou V, Arkell R, Timmons PM, Walsh JJ, Andrew RL, Swan D. 2001. Induction of the mammalian node requires Arkadia function in the extraembryonic lineages. Nature 410:825-830.
40. Niederlander C, Walsh JJ, Episkopou V, Jones CM. 2001. Arkadia enhances nodal-related signalling to induce mesendoderm. Nature 410:830-834.
41. Mukhopadhyay D, Ayaydin F, Kolli N, Tan SH, Anan T, Kametaka A, Azuma Y, Wilkinson KD, Dasso M. 2006. SUSP1 antagonizes formation of highly SUMO2/3-conjugated species. J. Cell Biol. 174:939-949.
42. Liew CW, Sun H, Hunter T, Day CL. 2010. RING domain dimerization is essential for RNF4 function. Biochem. J. 431:23-29.
43. Plechanovova A, Jaffray EG, McMahon SA, Johnson KA, Navratilova I, Naismith JH, Hay RT. 2011. Mechanism of ubiquitylation by dimeric RING ligase RNF4. Nat. Struct. Mol. Biol. 18:1052-1059.
44. Wang Z, Jones GM, Prelich G. 2006. Genetic analysis connects SLX5 and SLX8 to the SUMO pathway in Saccharomyces cerevisiae. Genetics 172: 1499-1509.
45. Mizutani A, Saitoh M, Imamura T, Miyazawa K, Miyazono K. 2010. Arkadia complexes with clathrin adaptor AP2 and regulates EGF signalling. J. Biochem. 148:733-741.
46. Hsu YH, Sarker KP, Pot I, Chan A, Netherton SJ, Bonni S. 2006. Sumoylated SnoN represses transcription in a promoter-specific manner. J. Biol. Chem. 281:33008-33018.
47. Wrighton KH, Liang M, Bryan B, Luo K, Liu M, Feng XH, Lin X. 2007. Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation. J. Biol. Chem. 282:6517-6524.
48. Sharma V, Antonacopoulou AG, Tanaka S, Panoutsopoulos AA, Bravou V, Kalofonos HP, Episkopou V. 2011. Enhancement of TGF-{beta} signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer. Cancer Res. 71:6438-6449.
49. Galanty Y, Belotserkovskaya R, Coates J, Jackson SP. 2012. RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. Genes Dev. 26:1179-1195.
50. Luo K, Zhang H, Wang L, Yuan J, Lou Z. 2012. Sumoylation of MDC1 is important for proper DNA damage response. EMBO J. 31:3008-3019.
51. Yin Y, Seifert A, Chua JS, Maure JF, Golebiowski F, Hay RT. 2012. SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev. 26:1196-1208.